






Diabetic ketoacidosis (DKA) is the most serious acute complication of Type 1 diabetes.  Detailed clinical data harbored by electronic health record (EHR) databases can be used to assess the impact of DKA performance improvement initiatives and generate novel disease insights.
Objectives
To examine trends in DKA outcomes surrounding performance improvement initiatives and identify clinical characteristics associated with treated cerebral edema.  
Design, Setting and Methods
The EHR database at our tertiary children’s hospital was interrogated using a business intelligence platform to identify patients admitted with DKA between April 2009 and May 2016.  Multivariable regression using robust standard errors to cluster patients with multiple encounters was used to examine temporal trends in the incidence of hypoglycemia, treated cerebral edema, central line placement, development of severe hyperchloremia, head computed tomography utilization, and hospital length of stay.  Trends in outcomes surrounding several performance improvement initiatives were examined.  
Results
Central line placement, head computed tomography utilization and the incidence of severe hyperchloremia decreased significantly throughout the study period.  Performance improvement initiatives were significantly associated with decreasing hospital length of stay and reduced variability in length of stay among patients with severe DKA.  Systolic blood pressure at presentation and during hospitalization was significantly associated with treatment for cerebral edema after adjusting for other biochemical indicators of disease severity.
Discussion
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Diabetic ketoacidosis (DKA) is the most serious acute complication of Type 1 diabetes and is associated with an estimated annual treatment cost of $90 million in the United States among children and adolescents.1  Evidence-based, consensus guidelines for DKA outline management strategies to optimize outcomes and reduce the incidence of mortality and cerebral edema.2  Institutional adoption of standardized approaches to DKA treatment based on these guidelines have helped to reduce management variability while leading to improvements in the incidence of hypokalemia, intensive care unit length of stay, bicarbonate use, antibiotic use, heparin prescriptions and cerebral edema.3,4  
The electronic health record (EHR) and computerized order entry have been used to facilitate uniformity in the management of DKA through ordersets and decision-support.3  Spurred by Meaningful Use incentives, the emergence of electronic health data collection and storage has generated large repositories of structured data elements harbored by many institutions that can be readily searched and continue to accumulate.5  The Institute of Medicine has recognized the potential of leveraging such data sources to support research endeavors and performance improvement initiatives as part of the strategic development of learning health care systems.6–9  
We sought to examine temporal trends in the management of DKA at our institution between 2009 and 2016 by interrogating an EHR-derived data warehouse.  We hypothesized that system-level changes in care, including mandating pediatric intensive care unit (PICU) admission for active DKA and implementation of an evidence-based guideline and orderset, would be associated with improved outcomes during this period.  Additionally, we hypothesized that this retrospective EHR-derived data could be used to identify novel patient characteristics associated with treated cerebral edema.  
2.0 	methods
This is a single-center, retrospective cohort study of patients with DKA identified through structured data from the EHR.  Approval was granted by the University of Pittsburgh Medical Center quality improvement (QI) project review board, an oversight body responsible for ensuring QI projects meet appropriate ethical standards, and by the University of Pittsburgh Institutional Review Board.   The study center is a 296-bed quaternary children’s hospital that is the main referral center for pediatric subspecialty care and acute childhood diseases in a region of approximately 5 million people.  Patients with DKA are cared for by attending pediatric intensivists, endocrinologists, nurse practitioners/physician assistants and all levels of trainees, including pediatric residents and both endocrinology and critical care fellows.  Our institution also has an active regional patient transport program with prehospital care of all transferred patients guided by a pediatric critical care fellow, either by phone or in-person.  
The primary goal of this study was to examine the impact on temporal trends in DKA outcomes surrounding two systematic changes in our institution’s management of DKA.  In April 2012, our institution mandated that all patients with DKA requiring an insulin infusion be admitted to the pediatric intensive care unit (PICU) until sufficient resolution allowed for transition to a maintenance insulin regimen.  In December 2012, an evidence-based DKA guideline outlining management of intravenous fluid and dextrose titration was made available to all clinicians at our institution (Figure 1).  Outcomes of interest included the incidence of cerebral edema, hypoglycemia, hyperchloremia, head computed tomography (CT) utilization, and central venous line (CVL) placements.  Secondary goals of this study included identifying biochemical parameters and patient characteristics associated with cerebral edema.
Criteria for PICU Admission
	Depressed level of consciousness
	Blood glucose > 1000 mg/dL
	Serum bicarbonate <14 mMol/L
	Any child requiring close monitoring per discretion of endocrinology or critical care 

PICU Fluid and Insulin Management
	Following initial resuscitation, initiate intravenous fluids (IVF) at two-fold maintenance rate, with adjustment per physician discretion.
	Avoid placing standing orders for urine replacement.
	Add dextrose to IVF when serum glucose <300 mg/dL.  Use a “two-bag system” to titrate dextrose concentrations between D5% and D10% as needed to maintain decline in blood glucose of less than 100 mg/dL/hour.
	Consider changing from 0.9% saline to 0.45% saline when dextrose is added to IVF.  The “two-bag system” can also be used to titrate to intermediate Na concentrations (such as 0.67% aqueous saline).  
	Add 20 mEq/L of potassium chloride to IVF when the serum potassium is less than 5 mEq/L and 20 mEq/L of potassium phosphate when the serum potassium is less than 4 mEq/L (total 40 mEq/L of potassium).  If ionized calcium is <1.0 mEq/L, consider using potassium chloride or potassium acetate instead of potassium phosphate.
	Insulin infusions should be ordered at 0.1 units/kg/hour.  Consider decreasing this dose to 0.05 – 0.08 units/kg/hour in children less than 5 years of age.

Transitioning to Maintenance Insulin (Subcutaneous or Insulin Pump)
	A patient is ready to initiate or resume a maintenance insulin regimen when the anion gap has closed and the serum bicarbonate is greater than or equal to 16 mEq/L.  
	Administer both long and short-acting insulin at the same time immediately prior to the patient eating.  Turn the insulin infusion off 30 minutes after maintenance insulin has been administered.
	Non-dextrose containing IVF should be continued at a maintenance rate following transition.





SAP BusinessObjects (SAP, Walldorf, Germany), a business intelligence platform, was used to interrogate a cloned EHR database containing information from all patient encounters at our institution during the study period.  Data were extracted in .xml format and organized for subsequent analysis using Microsoft Excel (Microsoft Corp., Redmond, WA USA).  All patients >1 month of age admitted from April 2009, when the current study center campus opened, to May 2016 with a final International Classification of Diseases Ninth (ICD-9) or Tenth (ICD-10) version diagnosis code consistent with DKA (ICD-9 codes 250.1x, 250.2x, 250.3x or ICD-10 E10.10 and E13.10) were included.  Validation of this search strategy was performed by reviewing unstructured assessments in admission history documentation of 10% of the identified patients.  
Demographic and clinical data included age, gender, pH and pCO2 from arterial, venous and capillary blood gases, serum glucose, blood urea nitrogen (BUN), beta-hydroxybutyrate (BOHB), sodium (Na), chloride (Cl), and Glasgow coma scale score (GCS).  Missing data (less than 1% of retrieved data) was populated through investigator chart review.  When applicable, arterial and capillary pH was adjusted to a venous scale by subtracting 0.05 and pCO2 was converted by adding 6 mmHg.   A correction factor of 1.6 mEq/L was added to Na for every 100 mg/dL increment of blood glucose above 100 mg/dL.  Head CT, mechanical ventilation, bolus mannitol and 3% aqueous saline utilization were assessed by searching for completed orders.  CVL placements were identified by searching nursing documentation for completed CVL insertion site assessments.  Patients with new-onset type 1 diabetes receive at least three days of insulin management teaching following resolution of DKA, with the duration of education influenced by patient and family comfort and knowledge acquisition.  To examine length of stay (LOS) in a population not subject to this teaching regimen, patients with established diabetes were distinguished from presentations of new-onset diabetes by searching all previous inpatient and outpatient encounters for ICD-9 or 10 codes consistent with a diagnosis of diabetes (supplementary materials in Appendix A).  This strategy isolated patients with known diabetes but did not separate the cohort into known and unknown diabetes status, since the remaining patients may have received diabetes care outside of our system and would not appear in our EHR database.
2.2	Data Analysis
Details of patient care provided at outside hospitals or during transport are not recorded as structured elements in our EHR and were not included in this analysis.   Patients with active DKA at the time of presentation to our institution, defined as meeting ICD criteria and a minimum pH less than 7.3, were included.  Minimum pH was used instead of initial pH to account for the downtrend in pH observed following initial resuscitation in some patients.  LOS was calculated as the difference of admission time and discharge time, excluding time in the emergency department.  Hypoglycemia was defined as a glucose less than 70 mg/dL and severe hyperchloremia as a Cl greater than 120 mMol/L.  
Linear and logistic regression analyses were examined the effects of performance improvement initiatives on outcomes.  We considered performance improvement initiatives to be in full effect in January 2013.  We also performed a sensitivity analysis varying the time the intervention was declared in effect.  This included testing the intervention in April 2012 when the requirement for PICU admission was established, as well as testing the intervention at the midpoint between the PICU admission requirement and hospital guideline implementation in August 2012.  An additional, conservative strategy tested the impact of excluding the cohort between April and December 2012.  Regression models incorporated robust standard errors clustered by patient to account for intragroup correlation among patients with multiple encounters during the study period.  The impact of time was considered both surrounding implementation of the performance improvement initiatives using a dichotomous intervention variable, as well as across the entire study period using a continuous week variable.  A likelihood ratio test determined whether there was a significant interaction between the intervention and week of the study period.  Interaction terms with significant likelihood ratio tests (P<0.2) were included in the final models.  A subgroup analysis examined outcomes in patients with severe DKA, defined as patients with a presenting pH less than 7.1.  
Systolic blood pressure (SBP) z scores were calculated based on age at time of admission and height z scores calculated using recorded height during the admission.  Patient height during admission was occasionally carried forward from a previous clinic visit or prior admission.  This risked biasing height z scores lower and therefore inflating SBP z scores.  To address this potential for bias, height z scores greater than 3 or less than -3 were eliminated.  The distribution of height z scores was then re-centered to zero by adding the median of the calculated distribution to each z score.  A multivariable model for treated cerebral edema was constructed with backward stepwise logistic regression, incorporating clinical parameters that demonstrated significant association with treatment.  Alpha was set to 0.05 and all P values are two-tailed.  Height and SBP z scores were calculated with R (www.r-project.org and R Studio Inc., Boston, MA, USA) using an open source function based on published Center for Disease Control and Prevention and National Institutes of Health standards for childhood height and blood pressure percentiles.10–12 All other analyses were performed using Stata 14.0 (StatCorp, College Station, TX, USA).  

3.0 	Results
Searching ICD-9 and 10 codes for DKA retrieved 1379 patients from our EHR, admitted between April 2009 and May 2016.  Excluding patients that did not have a documented pH less than 7.3 during their stay yielded 1225 patients, of which 742 were identified as patients with known diabetes and 588 had BOHB sampled during admission.  GCS was not available for one patient in the post-intervention period.  Patients in the post-intervention period were older, presented with a higher paCO2 and a lower BUN and had lower initial, minimum and maximum corrected Na values during hospitalization (Table 1).
The proportion of encounters with treated cerebral edema was 2.4% for the entire cohort, with 2.5% of pre-intervention encounters and 2.4% of post-intervention encounters receiving treatment, respectively (Table 5).  Regression analysis did not demonstrate any change in the incidence of patient encounters treated for cerebral edema or developing hypoglycemia surrounding system-level changes in management (Table 2).  The incidence of encounters undergoing central venous line placements, developing severe hyperchloremia, and undergoing head CT significantly decreased over the study period (Table 2).  This association was also apparent when patient encounters between April and December 2012 were excluded from analysis (Table 6).  The intervention was associated with a change in the slope of mean LOS for patients presenting with a pH less than 7.1, with a significant upward slope in the pre-intervention period changing to a significant downward slope in the post-intervention period (Table 3).  Figure 1 displays mean LOS for patients with known diabetes with a presenting pH less than 7.1.
Sufficient data was available for 926 patients to calculate z scores of SBP.  Backward stepwise regression followed by clustering for patients with multiple encounters identified presenting pH, paCO2, BUN, and systolic blood pressure z score to be associated with treatment for cerebral edema during hospitalization (Table 4).   Maximum SBP z score during hospitalization was significantly associated with treatment for cerebral edema after adjustment for presenting pH, paCO2, corrected Na, BUN and presenting SBP z score (Odds Ratio 1.85 [95% confidence interval 1.37 – 2.52]; P < 0.001).  Models with comparable associations were identified using unadjusted SBP z scores (data not shown).  Presenting BOHB was not associated with treatment for cerebral edema after adjustment for significant covariates.  







Table 1. Cohort characteristics stratified by intervention period and cerebral edema treatment
	Pre-Intervention	Post-Intervention	Cerebral Edema Treatment	No Cerebral Edema Treatment
Chracteristics	n = 565	n = 660		n = 30	n = 1195	
	Mean [95% CI]	Mean [95% CI]	P	Mean [95% CI]	Mean [95% CI]	P
Age (years)*	11.8 [11.2-12.3]	12.6 [12.1-13.0]	<0.01	12.3 [10.7-13.8]	12.2 [11.8-12.6]	0.93
pH*	7.16 [7.15-7.17]	7.16 [7.15-7.17]	0.37	7 [7-7]	7.16 [7.16-7.17]	<0.001
BUN (mg/dL)*	20 [19-21]	18 [18-19]	<0.01	31 [23-38]	19 [18-20]	<0.01
PvCO2 (mmHg)*	25 [24-25]	26 [25-26]	0.07	21 [18-24]	25 [25-26]	0.01
Corrected Na (mEq/L)*	140 [140-141]	137 [137-137]	<0.001	144 [141-148]	139 [138-139]	<0.01
Min corrected Na (mEq/L)	137 [136-137]	136 [135-136]	<0.001	139 [136-141]	136 [136-136]	0.02
Max corrected Na (mEq/L)	144 [143-144]	143 [142-143]	<0.01	152 [149-155]	143 [143-143]	<0.001
Glucose (mg/dL)*	469 [449-490]	453 [436-471]	0.24	712 [588-836]	454 [442-467]	<0.001
	n = 435	n = 491		n = 924	n = 902	
Max SBP z score	2.46 [2.34-2.58]	2.57 [2.42-2.71]	0.24	3.75 [3.19-4.31]	2.48 [2.38-2.58]	<0.001
SBP z score*	1.23 [1.11-1.37]	1.2 [1.06-1.33]	0.67	0.58 [-0.02-1.17]	1.23 [1.13-1.33]	0.03
	n = 565	n = 659		n = 30	n = 1194	
GCS score*	14.7 [14.56-14.83]	14.7 [14.6-14.8]	0.76	12.17 [10.8-13.5]	14.7 [14.7-14.8]	<0.001
			n = 587		n = 15	n = 572	





Table 2. Multivariable outcome models for all patients with active DKA (n = 1,224)
	Hypoglycemia(glucose <70 mg/dL)	Severe hyperchloremia (Cl >120 mEq/L)	CVL placement	Head CT obtained	Cerebral edema treatment	Hospital length of stay(log hours)
	OR	OR	OR	OR	OR	β
Characteristic	[95% CI]	[95% CI]	[95% CI]	[95% CI]	[95% CI]	[95% CI]
	P	P	P	P	P	P
	0.9	2.0	1.1	3.2	1.2	-0.026
Intervention	[0.4 - 1.8]	[1.0 - 4.1]	[0.3 - 3.5]	[1.2 - 8.3]	[0.3 - 4.6]	[-0.077 - 0.026]
	0.73	0.046	0.88	0.02	0.75	0.33
	1.0	0.996	1.0	0.994	1.0	0
Week	[1.0 - 1.0]	[0.993 - 0.9997]	[1.0 - 1.0]	[0.989 - 0.999]	[1.0 - 1.0]	[0.000 - 0.000]
	0.51	0.03	0.12	0.01	1.0	0.18
	1.0	0.9	1.0	1.0	1.0	-0.016
Age (years)	[0.9 - 1.0]	[0.9 - 0.9]	[1.0 - 1.0]	[0.9 - 1.0]	[0.9 - 1.1]	[-0.019 - -0.013]
	0.61	<0.001	0.58	0.41	0.94	<0.001
	1.4	1.4	2.3	1.2	0.8	-0.014
Female sex	[0.9 - 2.1]	[0.9 - 2.0]	[1.3 - 3.8]	[0.6 - 2.4]	[0.4 - 1.6]	[-0.042 - 0.014]
	0.13	0.10	<0.01	0.64	0.51	0.34
pH*	7.4	0.0005	0.001	0.01	0.001	-0.538
	[1.1 - 50.7]	[0.000 - 0.002]	[0.000 - 0.015]	[0.001 - 0.176]	[0.000 - 0.044]	[-0.663 - -0.413]
	0.04	<0.001	<0.001	<0.01	<0.01	<0.001
	1.0	0.9	1.0	1.0	0.9	-0.004
PvCO2 (mmHg)*	[0.9 - 1.0]	[0.9 - 0.9]	[1.0 - 1.0]	[0.9 - 1.0]	[0.9 - 1.0]	[-0.006 - -0.002]
	0.03	<0.001	0.75	0.26	0.03	<0.001
Corrected Na (mEq/L)*	1.0	1.2	1.1	1.0	1.0	0.004
	[0.9 - 1.0]	[1.2 - 1.3]	[1.0 - 1.1]	[1.0 - 1.1]	[1.0 - 1.1]	[0.001 - 0.007]
	0.48	<0.001	<0.01	0.67	0.52	<0.01
	0.8	0.9	0.7	0.8	0.9	-0.01
GCS score*	[0.7 - 0.9]	[0.8 - 1.1]	[0.6 - 0.8]	[0.7 - 1.0]	[0.8 - 1.0]	[-0.022 - 0.002]
	<0.01	0.38	<0.001	0.01	0.02	0.10
Glucose (mg/dL)*	1.0	1.001	1.0	1.0	1.0	0.0002
	[1.0 - 1.0]	[1.000 - 1.002]	[1.0 - 1.0]	[1.0 - 1.0]	[1.0 - 1.0]	[0.0001 - 0.0002]
	0.93	0.014	0.08	0.80	0.07	<0.001
	1.0	1.0	1.0	1.0	1.0	-0.002






Table 3. Multivariable models for patients with severe DKA (n = 340)
	Hypoglycemia (glucose <70 mg/dL)	Severe hyperchloremia (Cl >120 mEq/L)	CVL placement	Head CT obtained	Cerebral edema treatment	Hospital length of stay(log hours)
	OR	OR	OR	OR	OR	β
Characteristic	[95% CI]	[95% CI]	[95% CI]	[95% CI]	[95% CI]	[95% CI]
	P	P	P	P	P	P
	3.5	1.3	0.7	1.7	1.6	0.2
Intervention	[0.1 - 119.5]	[0.4 - 3.6]	[0.1 - 2.9]	[0.4 - 8.0]	[0.3 - 7.6]	[0.0 - 0.4]
	0.490	0.66	0.58	0.48	0.54	<0.01
	1.0	1.0	1.0	1.0	1.0	0.001






Age (years)	[0.9 - 1.2]	[0.9 - 1.0]	[0.9 - 1.0]	[0.8 - 1.0]	[0.9 - 1.1]	[-0.025 - -0.015]
	0.55	0.67	0.12	0.01	0.89	<0.001
	1.2	1.1	3.2	3.0	1.2	-0.003
Female sex	[0.6 - 2.8]	[0.6 - 2.0]	[1.3 - 7.5]	[0.8 - 10.4]	[0.5 - 3.1]	[-0.049 - 0.043]
	0.61	0.67	<0.01	0.09	0.74	0.90
	0.6	0.0004	0.0002	0.003	0.001	-0.816
pH*	[0.0 - 50.5]	[0.0 - 0.02]	[0.00 - 0.04]	[0.0 - 0.4]	[0.0 - 0.2]	[-1.100 - -0.532]
	0.81	<0.001	<0.01	0.02	0.01	<0.001
PvCO2 (mmHg)*	1.0	0.9	1.0	0.9	0.9	-0.005
	[0.9 - 1.0]	[0.9 - 1.0]	[0.9 - 1.0]	[0.9 - 1.0]	[0.9 - 1.0]	[-0.008 - -0.001]
	0.16	<0.001	0.32	0.21	0.04	<0.01
Corrected Na (mEq/L)*	1.0	1.2	1.1	1.1	1.0	0.003
	[0.9 - 1.1]	[1.1 - 1.3]	[1.0 - 1.1]	[1.0 - 1.2]	[1.0 - 1.1]	[-0.001 - 0.007]
	0.74	<0.001	0.03	0.21	0.49	0.19
GCS score*	0.8	0.9	0.7	0.8	0.9	-0.008
	[0.7 - 1.0]	[0.7 - 1.1]	[0.6 - 0.9]	[0.7 - 1.0]	[0.8 - 1.0]	[-0.020 - 0.004]
	0.01	0.24	<0.01	0.01	0.03	0.20
Glucose (mg/dL)*	1.0	1.0	1.0	1.0	1	0
	[1.0 - 1.0]	[1.0 - 1.0]	[1.0 - 1.0]	[1.0 - 1.0]	[1.0 - 1.0]	[0.000 - 0.000]
	0.09	0.32	0.02	0.43	0.23	0.82
BUN (mg/dL)*	1.0	1.0	1.1	1.0	1.0	0.001











Corrected Na (mEq/L)	1.08 [0.99-1.17]	0.07
BUN (mg/dL)	1.05 [1.02-1.09]	<0.01





















Using data collected directly from an EHR database, we demonstrate improvements in pediatric DKA outcomes over time at a quaternary children’s hospital.  To the best of our knowledge, the present study also represents the largest reported cohort to date examining biochemical risk factors for cerebral edema in children with DKA and is the first study to identify SBP as significantly associated with cerebral edema treatment.  Two system level changes, (1) mandated PICU admission for all DKA patients requiring an insulin infusion and (2) implementation of an evidence-based DKA guideline with an accompanying orderset, were associated with improvements in LOS for patients presenting with a pH less than 7.1.  Post-intervention confidence intervals narrowed suggesting a decrease in practice variability, though this may also reflect the larger number of patients in the post-intervention cohort compared to pre-intervention.  
Guideline implementation for DKA management has been shown to reduce LOS at other institutions.3,13,14  Pre-intervention, mean LOS for patients in the present cohort was comparable to the reported national mean LOS for DKA at 38 children’s hospitals (2.2 +/- 1.6 days versus 2.8 +/- 0.8 days).15  Our study intervention consisted of changes in DKA treatment predominantly influencing components of medical management such as fluid titration and response times to laboratory results, with resultant improvements in LOS for patients presenting with a pH less than 7.1.  Socioeconomic characteristics such as poverty and type of insurance are also determinants of LOS in DKA.16 Focusing on known diabetic LOS in the present study excluded the contribution of inpatient teaching time for new diagnoses, which is typically 2-3 days at our institution, but did not exclude other social and educational factors influencing LOS in the cohort.  Educational resources for patients with known diabetes with DKA did not change substantially throughout the study period, reducing the likelihood of unaddressed confounding in the time series analysis.  
Female sex was independently associated with CVL placement after controlling for other biochemical parameters representative of disease severity, potentially reflecting differences in amount and distribution of adipose tissue imposing challenges for vascular access in females.20 It is unclear whether the downtrend in CVL utilization across the entire timespan indicates a change in practice specific to DKA or is reflective of overall trends at our institution.  DKA is a prothrombotic state characterized by hemoconcentration, increased platelet count, decreased partial thromboplastin time, low protein C and high factor VIII, and is therefore associated with an elevated risk of CVL associated thrombosis.17 Increasing clinician mindfulness of this aspect of management may be responsible for improvements over time.  Similarly, the known association between hyperchloremia and length of stay may be responsible for improved attention to fluid transition resulting in the evident ongoing reductions in the incidence of hyperchloremia in the post-intervention period.18 Declining utilization of head CT in patients with DKA indicates increasing recognition that this diagnostic study does not frequently influence management.19
Presenting pH, BUN and paCO2 were independently associated with treatment for cerebral edema in this cohort, findings that are compatible with previous reports. In a sentinel study, Glaser et al. noted the association between paCO2, BUN and cerebral edema in 61 children.26  Fiordalsi et al. reported an association with disease severity as evidenced by presenting pH, serum bicarbonate, paCO2 and BUN and cerebral edema in 635 children using prospectively collected data.27  A separate study by Glaser et al. reported the relationship between presenting paCO2 and cerebral ventricle size as a surrogate for subclinical edema in 41 children.28  Mahoney et al. reported an association with pH, paCO2 and brain herniation among 153 children with DKA.29  This EHR-data collected in this study can be used to hone performance improvement initiatives by providing objective thresholds based on historic probabilities for risk stratification to guide resource intensity. 
Hypertension has been previously described as a feature of DKA and frequently occurs despite intravascular volume depletion secondary to the osmotic diuresis that precedes presentation.  In a study of 33 diabetic children in DKA, 82% were hypertensive during the first 6 hours of admission and more than 50% remained hypertensive at their second outpatient follow-up.30    Our cohort’s mean presenting z score corresponds to approximately the 88th percentile of SBP for age.  The physiologic mechanism of hypertension in DKA is not understood, though may be related to excess catecholamines, increased circulating cortisol, pain and anxiety, or release of antidiuretic hormone secondary to hyperosmolality.31–33  Whether hypertension contributes to vasogenic cerebral edema in patients with DKA or serves as a protective response to preserve cerebral perfusion is not known.30  In the present study, lower presenting SBP z score was associated with treatment for cerebral edema, as was a greater maximum SBP z.  Profound dehydration in patients with severe DKA may mitigate a compensatory hypertensive response.  Further clarification regarding individual temporal increases in blood pressure surrounding neurologic decompensation would help clarify the utility of rising SBP as a harbinger of worsening cerebral edema in this population.
This study demonstrates the utility of EHR-housed data to meet the needs of both performance improvement initiatives, as well as clinical investigations.  Efforts to standardize common inpatient care processes through the implementation of evidence-based guidelines have helped to reduce management variability in a number of childhood diseases and clinical scenarios, such as bronchiolitis, asthma and the ordering of blood cultures.34–36  Business intelligence platforms have been successfully used to guide strategic enterprise initiatives in health care.37    Intersecting performance improvement initiatives with queryable EHR databases offers a facile method of tracking guideline adherence and refining clinical pathways without the need for time-intensive chart review.  The association between SBP and treatment for cerebral edema in the present study demonstrates the potential for leveraging EHR data for novel disease insights.  
This study is limited by its retrospective design.  Apparent severity of the cohort may have been reduced by exclusion of pre-hospital data in analysis.  Likewise, patients who received treatment for cerebral edema prior to arrival but not following admission were not counted as cerebral edema cases.  Defining cerebral edema as receiving treatment with either mannitol or 3% aqueous saline may have introduced selection bias by excluding patients with clinically relevant cerebral edema who did not receive treatment.  The prevalence of cerebral edema in the current study, 2.4%, is higher than studies that have relied on billing codes to identify cerebral edema, but is comparable to studies that have relied on clinical documentation.3,38  It is possible that the observed association between cerebral edema and pH, BUN and paCO2 were driven by decisions to treat based on the known relationships between these parameters and cerebral edema rather than by the patient’s clinical appearance.  Further, as the data was collected from a training institution, orders for mannitol or 3% aqueous saline may have been placed by trainees less familiar with appropriate DKA management.  However, we expect that the usual hierarchy of clinical supervision led to the delivery of appropriate care in the vast majority of the cases.  

5.0 	conclusion
Analyzing structured EHR data we have demonstrated that system-level changes in the management of DKA were associated with improved outcomes at our institution.  Additionally, we replicated associations between presenting biochemical parameters and cerebral edema in the largest cohort to date and we identified hypertension as a clinical parameter that may forewarn of neurologic decompensation.   Further study is warranted to better understand the relationship between blood pressure and cerebral edema in children with DKA.
 
APPENDIX A: DIAGNOSIS CODES
icd-9 and 10 codes used to identify previous episodes of diabetes-related care:
ICD-9: ANY CODE 250.00 – 250.93




APPENDIX B: SUPPLEMENTAL TABLES





Severe hyperchloremia (Cl >120 mEq/L)	32%	23%	<0.01	30%	23%	<0.01	29%	22%	<0.01	32%	22%	23%	<0.01
Hypoglycemia (blood glucose <70 mg/dL)	10%	11%	0.70	10%	11%	0.52	10%	11%	0.79	10%	11%	11%	0.92
LOS (hours)	66.30	65.81	0.83	66.75	65.45	0.57	68.02	64.22	0.09	66.30	64.22	--	0.36
Log LOS (log hours)	1.755	1.751	0.79	1.758	1.748	0.52	1.762	1.744	0.20	1.755	1.744	1.783	0.47





	Hypoglycemia (glucose <70 mg/dL)	Severe hyperchloremia (Cl >120 mEq/L)	CVL placement	Head CT obtained	Cerebral edema treatment	Hospital length of stay (log hours)
	OR	OR	OR	OR	OR	Coefficient
Characteristic	[95% CI]	[95% CI]	[95% CI]	[95% CI]	[95% CI]	[95% CI]
	P	P	P	P	P	P
	1.0	2.5	1.8	1.2	0.4	-0.003
Intervention	[0.4 - 2.8]	[1.0 - 6.3]	[0.5 - 6.9]	[0.3 - 4.6]	[0.1 - 2.5]	[-0.1 - 0.1]
	0.95	0.06	0.37	0.77	0.31	0.92
	1.0	0.996	1.0	1.0	1.0	0.000
Week	[1.0 - 1.0]	[0.992 - 0.9998]	[1.0 - 1.0]	[1.0 - 1.0]	[1.0 - 1.0]	[0.0 - 0.0]
	0.81	0.04	0.03	0.40	0.27	0.58
	1.0	0.9	1.0	1.0	1.0	-0.017
Age (years)	[0.9 - 1.0]	[0.9 - 0.9]	[0.9 - 1.0]	[0.9 - 1.0]	[0.9 - 1.1]	[-0.020 - -0.014]
	0.68	<0.001	0.45	0.38	0.87	<0.001
	1.5	1.5	2;4	1.2	0.8	-0.010
Female sex	[1.0 - 2.4]	[1.0 - 2.2]	[1.3 - 4.2]	[0.6 - 2.4]	[0.4 - 1.6]	[-0.040 - 0.021]
	0.05	0.06	<0.01	0.61	0.46	0.54
	7.7	0.0004	0.0004	0.01	0.001	-0.518
pH*	[1.0 - 59.8]	[0.0000 - 0.002]	[0.000 - 0.006]	[0.001 - 0.165]	[0.00 - 0.06]	[-0.650 - -0.386]
	0.05	<0.001	<0.001	<0.01	<0.01	<0.001
	1.0	0.9	1.0	1.0	0.9	-0.003
PvCO2 (mmHg)*	[0.9 - 1.0]	[0.9 - 0.9]	[1.0 - 1.1]	[0.9 - 1.0]	[0.9 - 1.0]	[-0.005 - -0.001]
	0.06	<0.001	0.82	0.20	0.01	<0.01
	1.0	1.3	1.1	1.0	1.0	0.004
Corrected Na (mEq/L)*	[0.9 - 1.0]	[1.2 - 1.3]	[1.0 - 1.1]	[1.0 - 1.1]	[1.0 - 1.1]	[0.001 - 0.006]
	0.53	<0.001	<0.01	0.69	0.65	<0.01
	0.8	0.9	0.7	0.8	0.9	-0.013
GCS score*	[0.7 - 1.9]	[0.7 - 1.1]	[0.6 - 0.9]	[0.7 - 1.0]	[0.8 - 1.0]	[-0.026 - -0.001]
	<0.001	0.24	<0.01	0.04	0.05	0.03
	1.0	1.0	1.0	1.0	1.0	0.0002
Glucose (mg/dL)*	[1.0 - 1.0]	[1.0 - 1.0]	[1.0 - 1.0]	[1.0 - 1.0]	[1.0 - 1.0]	[0.0001 - 0.0002]
	0.68	0.05	0.15	0.77	0.09	<0.001
	1.0	1.0	1.0	1.0	1.0	-0.003
BUN (mg/dL)*	[1.0 - 1.0]	[1.0 - 1.0]	[1.0 - 1.0]	[1.0 - 1.1]	[1.0 - 1.1]	[-0.005 - -0.001]
	0.20	1.00	0.06	0.06	<0.01	<0.01
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